Concepedia

Author

Michelle Apperson

University of California, Davis

Also Known As

Apperson, Michelle Louise, M Apperson, M L Apperson, M. Apperson, MICHELLE APPERSON, Michelle Apperson, Michelle L. Apperson, Nataliya Voloshina

35

Publications

2.9K

Citations

21

H-Index

64

Concepts

All Affiliations

University of California, DavisUniversity of California Davis Medical CenterCalifornia Institute of TechnologyUniversity of BaselCleveland Clinic
MA

About

Michelle Apperson is an author at University of California, Davis specializing in medicine, neurology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

1.6K

2

Natural Sciences

2

2

82

3

Social Sciences

2

2

349

4

Biochemistry

2

2

339

5

Health Sciences

1

1

896

Michelle Apperson

×

18

Publications

2.6K

Citations

17

H-Index

YearCitations

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree,

The Lancet

2018

896

The major tyrosine-phosphorylated protein in the postsynaptic density fraction is N-methyl-D-aspartate receptor subunit 2B.

In Sung Moon, Michelle Apperson, Mary B. Kennedy

Proceedings of the National Academy of Sciences

1994

310

Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis

Robert J. Fox, Christopher S. Coffey, Robin Conwit,

New England Journal of Medicine

2018

270

Citron Binds to PSD-95 at Glutamatergic Synapses on Inhibitory Neurons in the Hippocampus

Wandong Zhang, Michelle Apperson, Mary B. Kennedy

Journal of Neuroscience

1999

189

Characterization of Densin-180, a New Brain-Specific Synaptic Protein of the<i>O</i>-Sialoglycoprotein Family

Michelle Apperson, Il Soo Moon, Mary B. Kennedy

Journal of Neuroscience

1996

158

Identification and validation of suitable endogenous reference genes for gene expression studies in human peripheral blood

Boryana Stamova, Michelle Apperson, Wynn L. Walker,

BMC Medical Genomics

2009

131

Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MS

Robert J. Fox, Andrew Chan, Ralf Gold,

Neurology Clinical Practice

2016

104

Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial

Bruce Cree, Gary Cutter, Jerry S. Wolinsky,

The Lancet Neurology

2020

99

Primed mesenchymal stem cells package exosomes with metabolites associated with immunomodulation

Megan R. Showalter, Benjamin Wancewicz, Oliver Fiehn,

Biochemical and Biophysical Research Communications

2019

97

Gene Expression in Peripheral Blood Differs after Cardioembolic Compared with Large-Vessel Atherosclerotic Stroke: Biomarkers for the Etiology of Ischemic Stroke

Huichun Xu, Yang Tang, Dazhi Liu,

Journal of Cerebral Blood Flow & Metabolism

2008

87

Page 1